Related Experiment Video

Updated: Mar 11, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.4K

Expression and methylation of circulating microRNA-510 in essential hypertension

Ramalingam Krishnan1, Panagal Mani2, Pethanen Sivakumar3

  • 1Advance Research Centre, Narayana Medical College and Hospital, Nellore, India.

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|November 25, 2016
PubMed

Insights

Researchers identified miR-510 as a potential biomarker for hypertension (HTN). This microRNA was found at higher levels in HTN patients, suggesting it could aid in early diagnosis and new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiovascular Medicine

Background:

  • Hypertension (HTN) is a prevalent global disease, particularly in developing nations.
  • HTN significantly impacts endothelial cell function, leading to severe conditions like cardiovascular and kidney disease.
  • Current early diagnosis and treatment strategies for HTN remain suboptimal.

Purpose of the Study:

  • To investigate the role of microRNAs in the pathogenesis of hypertension.
  • To identify novel biomarkers for the early detection of HTN.
  • To explore potential microRNA-based therapeutic targets for HTN.

Main Methods:

  • Analysis of microRNA expression levels in blood samples from HTN patients and healthy controls.
  • Quantitative methylation analysis to assess epigenetic modifications related to microRNA expression.
  • Statistical analysis to determine significant differences in miR-510 levels.

Main Results:

  • miR-510 was significantly upregulated in blood samples from patients with hypertension compared to controls.
  • Methylation analyses confirmed the upregulation of miR-510 in HTN patient samples.
  • No significant differences in miR-510 levels were observed in the control group.

Conclusions:

  • miR-510 shows potential as a novel diagnostic biomarker for hypertension.
  • The findings suggest miR-510 could be a promising therapeutic target for managing HTN.
  • Further research is warranted to validate miR-510's clinical utility in HTN management.

More Related Videos

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

2.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690